HemoSmart Medical Technology

Founded in 2018, HemoSmart Medical Technology Co., Ltd. (hereinafter referred to as HemoSmart Medical) is a company that is built upon microfluidics as its underlying technology, focusing on a series of rapid in vitro diagnostic products, and cooperates closely with China's top three hospitals. The team is composed of doctors returning to China, foreign doctors, members of the Royal Academy and senior executives of renowned Chinese pharmaceutical enterprises. The company holds more than 70 independent patents, including more than 30 invention patents and nearly 10 international patents. The company's R&D and production enterprises include, inter alia, Suzhou Bofu Pharmaceutical, ShangHai BangXian Medical, and Microflo Scientific in UK.. The scope of the business encompasses the following areas: intelligent automatic high-speed production system for microdroplets; rapid screening system for circulating tumor cells; rapid enrichment kit for immune T-cells; rapid detection kit for pathogenic bacteria; trace detection kit for misfolded proteins in neurodegenerative diseases; and preparation of microcapsules. Since its establishment, more than 20 products have been developed in the areas of rapid sorting of circulating tumor cells responsible for breast cancer, lung cancer, colorectal cancer and prostate cancer; rapid screening of immune cells in peripheral blood; rapid detection of bacteremia.